Existing drug class may help patients with skin cancer that resists standard treatments

Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not respond to the latest cancer treatments, a new study shows.

Keto Cholesterol study SHOCKS scientific community | LMHRs & heart disease
- NASA is shutting down some official social media accounts, including the Curiosity rover's handle - Ian Carlos Campbell
- Under RFK Jr., COVID shots will only be available to people 65+, high-risk groups - Beth Mole
- Offbeat Mystery Comedy on Prime Video Is A Worthy Proof Of Concept For Multi-Talented A-Lister - Robert Scucci
- Current Mortgage Rates: June 11, 2025
- YRKKH Written Update 11 August 2024: Abhira Refuses to Marry Arman as Ruhi’s Plan Unfolds! - Aaradhana Chaurasia
- Meta AI gains video editing capabilities - Ivan Mehta

If this Prophet boards your aircraft – take the next flight
- Resident Evil Requiem features terror in first and third-person views - Mike Minotti
- Bioengineered skin doubles burn healing speed in preclinical models
- After Google, Meta loses public policy head in India - Jagmeet Singh
- Playhouse MD reimagines pediatric healthcare with play - Dean Takahashi
- What Is the Average Weight for Women? Based on Age and Height - Lindsay Curtis
- How To Choose the Right Sunscreen for You - Sherri Gordon